Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Stem Cell Firm Selects Newcastle for European Base

Published: Friday, February 08, 2008
Last Updated: Friday, February 08, 2008
Bookmark and Share
RNL Bio has signed an initial 12 month tenancy agreement for a unit at the ‘Cels at Newcastle’ bio-incubator at Newcastle University's Medical School.

A Korean biotechnology company has opened its European division at Newcastle University to develop its stem cell research programme.

RNL Bio was established in Korea in 1961 and specializes in stem cell research as well as developing therapeutic products and regenerative medicine. The firm currently employs around 85 members of staff and has been brought to the North East following a joint venture between One NorthEast, the North East Stem England Cell Institute (NESCI) and Cels, the organization driving the growth of the North East’s healthcare economy.

RNL Bio has signed an initial 12 month tenancy agreement for a unit at the ‘Cels at Newcastle’ bio-incubator at Newcastle University's Medical School. The move is set to create three jobs in the sector in the coming weeks and aims to create around 14 new roles in the future.

The firm will use its Newcastle base to develop stem cell therapy products for diseases by isolating and culturing stem cells derived from a range of sources. They are also funding research projects in the laboratories of the North-East England Stem Cell Institute (NESCI).

RNL Bio is also currently conducting research at its site in Korea to develop a new product developed from a herb for the treatment of diabetes.

Professor Michael Whitaker, Dean of Development in the Faculty of Medical Sciences at Newcastle University and co-Director of NESCI, said: “This is an important inward investment opportunity for the North-East – we hope the first of many in stem cells. We are very pleased to welcome RNL Bio to the incubator space operated by CELS at the Medical School. Scientists and clinicians in NESCI will be working closely with RNL Bio to help them realize their ambitions in Europe.”

Ben Fisher, Investment & Aftercare Specialist Advisor at One NorthEast said: “We are delighted that RNL Bio has decided to open its European hub in the North East as this is testament to the incredible work in stem cell technology that is already taking place in the region.

“The inward investment team at One NorthEast visited the company at its headquarters in Korea to sell the benefits of the region and then worked closely in coordinating regional bodies to secure the commitment of RNL Bio. This investment is of international importance and is fantastic news for the region.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Stem Cell Research Could aid Male Infertility
Study helps scientists to understand more about how animals produce sperm.
Wednesday, July 12, 2006
Scientific News
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Improving Drug Production with Computer Model
A model has been developed that can be used to improve and accelerate the production of biotherapeutics, cancer drugs, and vaccines.
Defining Immortality of Stem Cells
Researchers defined the mechanisms underlying increased protein quality control of pluripotent stem cells.
BioCision Forms MedCision
The new company will focus on technologies for the management and automation of vital clinical processes.
Enhancing CRISPR to Explore Further
Researchers have developed sOPTiKO, a more efficient and controllable CRISPR genome editing platform.
Regenerating Diseased Hearts
Researchers from the University of Otago have probed the potential of adult stem cell types to repair diseased hearts.
Stem Cells Police Themselves to Reduce Scarring
Scientists have discovered stem cells in muscle fibers change gene expressions to respond to injury.
Bright Red Fluorescent Protein Created
Scientists have created a bright red, fluorescent protein that could be used to track essential cellular processes.
Protein Self-Regulates Abundance
Researchers have uncovered how a protein, that plays a crucial role in embryonic stem cell renewal, is regulated.
Topical Immunotherapy Effective Against Early Skin Cancer
Combination of two commonly used drugs triggers immune response against precancerous skin lesions.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!